Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Expert Review of Clinical Pharmacology|May 22, 2016
Three-month paliperidone palmitate - a new treatment option for schizophreniaMiquel Bernardo, Miquel Bioque
Expert Opinion on Pharmacotherapy|September 25, 2018
The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophreniaMiquel Bioque, Miquel Bernardo
Journal of Psychiatric Practice|March 7, 2018
Relationship Between Antipsychotic Medications and Cerebrovascular Disease in Patients With Serious Mental IllnessNuria Berrocal-Izquierdo, Miquel Bioque, Miguel Bernardo
International Clinical Psychopharmacology|October 19, 2016
Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?Nuria Berrocal-Izquierdo, Miquel Bioque, Miguel Bernardo
International Journal of Psychiatry in Clinical Practice|November 23, 2017
An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study)Eduard Parellada, Miquel Bioque, Manuel Serrano, et al.
Journal of Psychiatric Research|July 29, 2023
Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?Vicent Llorca-Bofí, Miquel Bioque, Maria Font, et al.
Molecular Psychiatry|January 31, 2026
Neuroinflammation: an unfortunate term to describe schizophreniaVicent Llorca-Bofí, Eduard Parellada, Constanza Morén, et al.
Pageof 11